Icecure Medical Ltd (ICCM)

IceCure Medical Ltd is a commercial-stage medical device company listed on NASDAQ under the ticker ICCM. The company focuses on the research, development, and marketing of cryoablation systems, disposables, and related technologies used in tumor treatment across the United States, Japan, India, China, Israel, and other international markets. Its portfolio includes the ProSense single-probe cryoablation system for malignant breast tumors, associated consumables such as CryoProbes needles and guiding needles/introducers, and the IceSense3 system for applications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. IceCure is also developing the XSense single-probe system and the MSense multi-probe system. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. Incorporated in 2006, IceCure Medical is headquartered in Caesarea, Israel.

Jump directly to the stock analysis sections supported by the latest available data.